Skip to main content
Top
Published in: BMC Nephrology 1/2020

01-12-2020 | Care | Research article

Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators

Authors: Tazeen Hasan Jafar, Chandrika Ramakrishnan, Oommen John, Abha Tewari, Benjamin Cobb, Helena Legido-Quigley, Yoon Sungwon, Vivekanand Jha

Published in: BMC Nephrology | Issue 1/2020

Login to get access

Abstract

Background

Despite the high and rising burden of chronic kidney disease (CKD) in South Asia, factors that influence access to CKD care at the community level have not been studied previously, especially in the rural areas. We conducted a mixed methods study and interviewed key stakeholders to explore the views and experiences of key stakeholders, and identify barriers and potential facilitators that influence access to CKD care at the primary care level in rural India.

Methods

A total of 21 stakeholders participated in the study. We conducted 15 in-depth interviews on a purposive sample of stakeholders (CKD patients, healthcare providers and health planners) and one focus group discussion with 6 community health workers. The interviews were audio-recorded and transcribed verbatim. We employed the Lévesque’s framework for access to care to base interview guides and structure the initial codes. By inductive and deductive approaches, thematic analysis was undertaken using QSR NVivo version 11.

Results

The major patient-level barriers to CKD care as reported by the most patients and healthcare providers was poor knowledge and awareness of CKD. Health system-level barriers included shortages of skilled healthcare professionals and medicines, fragmented referrals pathways to the specialists at the hospitals with inadequate follow up care. Many patients and healthcare providers, when asked about areas for improving access to CKD care, reported educational initiatives to increase awareness of CKD among healthcare providers and patients, provision of CKD related supplies, and a systems-level approach to care coordination including task shifting by engaging community health workers in CKD care, as potential facilitators.

Conclusions

We identified several barriers to access CKD care at the primary care level in rural India that need urgent attention. Targeted CKD screening programs and CKD specific educational initiatives may improve awareness of CKD. Additionally, primary care infrastructure needs to be strengthened for CKD care, ensuring trained staff, availability of essential diagnostics and medications, and creating efficient referral pathways for quality CKD care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.CrossRefPubMed Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.CrossRefPubMed
2.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed
3.
go back to reference GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.CrossRef GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.CrossRef
4.
go back to reference Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (screening and early evaluation of kidney disease) study. BMC Nephrol. 2013;14:114.PubMedCentralCrossRefPubMed Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (screening and early evaluation of kidney disease) study. BMC Nephrol. 2013;14:114.PubMedCentralCrossRefPubMed
5.
go back to reference Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study. BMC Nephrol. 2014;15:90.PubMedCentralCrossRefPubMed Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study. BMC Nephrol. 2014;15:90.PubMedCentralCrossRefPubMed
6.
go back to reference Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10.PubMedCentralCrossRefPubMed Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012;13:10.PubMedCentralCrossRefPubMed
7.
go back to reference Modi GK, Jha V. The incidence of end-stage renal disease in India: a population-based study. Kidney Int. 2006;70(12):2131–3.CrossRefPubMed Modi GK, Jha V. The incidence of end-stage renal disease in India: a population-based study. Kidney Int. 2006;70(12):2131–3.CrossRefPubMed
9.
go back to reference Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.CrossRefPubMed Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.CrossRefPubMed
10.
go back to reference The Look AHEAD Research Group, et al. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801–9.PubMedCentralCrossRef The Look AHEAD Research Group, et al. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801–9.PubMedCentralCrossRef
11.
go back to reference Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703–13.PubMedCentralCrossRef Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703–13.PubMedCentralCrossRef
12.
go back to reference Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016;67(5):728–41.CrossRefPubMed Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016;67(5):728–41.CrossRefPubMed
13.
go back to reference Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181–92.PubMedCentralCrossRefPubMed Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181–92.PubMedCentralCrossRefPubMed
14.
go back to reference Flynn C, Bakris GL. Blood pressure targets for patients with diabetes or kidney disease. Curr Hypertens Rep. 2011;13(6):452–5.CrossRefPubMed Flynn C, Bakris GL. Blood pressure targets for patients with diabetes or kidney disease. Curr Hypertens Rep. 2011;13(6):452–5.CrossRefPubMed
15.
go back to reference Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–7.CrossRefPubMed Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920–7.CrossRefPubMed
16.
go back to reference Cummings DM, Larsen LC, Doherty L, Lea CS, Holbert D. Glycemic control patterns and kidney disease progression among primary care patients with diabetes mellitus. J Am Board Fam Med. 2011;24(4):391–8.CrossRefPubMed Cummings DM, Larsen LC, Doherty L, Lea CS, Holbert D. Glycemic control patterns and kidney disease progression among primary care patients with diabetes mellitus. J Am Board Fam Med. 2011;24(4):391–8.CrossRefPubMed
17.
go back to reference Ferguson TW, Tangri N, Tan Z, James MT, Lavallee BDA, Chartrand CD, et al. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective. Kidney Int. 2017;92(1):192–200.CrossRefPubMed Ferguson TW, Tangri N, Tan Z, James MT, Lavallee BDA, Chartrand CD, et al. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective. Kidney Int. 2017;92(1):192–200.CrossRefPubMed
18.
go back to reference McGill JB, Brown WW, Chen S-C, Collins AJ, Gannon MR. Kidney early evaluation program (KEEP): findings from a community screening program. Diabetes Educ. 2004;30(2):196–206.CrossRefPubMed McGill JB, Brown WW, Chen S-C, Collins AJ, Gannon MR. Kidney early evaluation program (KEEP): findings from a community screening program. Diabetes Educ. 2004;30(2):196–206.CrossRefPubMed
19.
go back to reference Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63(5):789–97.CrossRefPubMed Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63(5):789–97.CrossRefPubMed
20.
go back to reference Bajpai V. The challenges confronting public hospitals in India, their origins, and possible solutions. Adv Public Health. 2014;2014:27.CrossRef Bajpai V. The challenges confronting public hospitals in India, their origins, and possible solutions. Adv Public Health. 2014;2014:27.CrossRef
23.
go back to reference Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307–19.CrossRefPubMed Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307–19.CrossRefPubMed
24.
go back to reference Luk AO, Li X, Zhang Y, Guo X, Jia W, Li W, et al. Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry. Diabet Med. 2016;33(9):1230-9.CrossRefPubMed Luk AO, Li X, Zhang Y, Guo X, Jia W, Li W, et al. Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry. Diabet Med. 2016;33(9):1230-9.CrossRefPubMed
25.
go back to reference Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed
26.
go back to reference Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int Suppl. 2013;3(2):157–60.CrossRef Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int Suppl. 2013;3(2):157–60.CrossRef
27.
go back to reference Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized TrialPromoting blood pressure control in a developing country. Ann Intern Med. 2009;151(9):593–601.CrossRefPubMed Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized TrialPromoting blood pressure control in a developing country. Ann Intern Med. 2009;151(9):593–601.CrossRefPubMed
28.
go back to reference Jafar TH, Allen JC, Jehan I, Hameed A, Saffari SE, Ebrahim S, et al. Health education and general practitioner training in hypertension management: long-term effects on kidney function. Clin J Am Soc Nephrol. 2016;11(6):1044–53.PubMedCentralCrossRefPubMed Jafar TH, Allen JC, Jehan I, Hameed A, Saffari SE, Ebrahim S, et al. Health education and general practitioner training in hypertension management: long-term effects on kidney function. Clin J Am Soc Nephrol. 2016;11(6):1044–53.PubMedCentralCrossRefPubMed
29.
go back to reference Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, et al. Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial. Ann Intern Med. 2016;165(6):399–408.PubMedCentralCrossRefPubMed Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, et al. Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial. Ann Intern Med. 2016;165(6):399–408.PubMedCentralCrossRefPubMed
30.
go back to reference Piette JD, List J, Rana GK, Townsend W, Striplin D, Heisler M. Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management. Circulation. 2015;132(21):2012–27.PubMedCentralCrossRefPubMed Piette JD, List J, Rana GK, Townsend W, Striplin D, Heisler M. Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management. Circulation. 2015;132(21):2012–27.PubMedCentralCrossRefPubMed
31.
go back to reference Jafar TH, Agarwal SK. A decade after the KDOQI CKD guidelines: a perspective from South Asia. Am J Kidney Dis. 2012;60(5):731–3.CrossRefPubMed Jafar TH, Agarwal SK. A decade after the KDOQI CKD guidelines: a perspective from South Asia. Am J Kidney Dis. 2012;60(5):731–3.CrossRefPubMed
32.
go back to reference Levesque J-F, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12:18.PubMedCentralCrossRefPubMed Levesque J-F, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12:18.PubMedCentralCrossRefPubMed
33.
go back to reference Morse JM, Richards L. Readme first for a user's guide to qualitative methods. Thousand Oaks: Sage; 2002. Morse JM, Richards L. Readme first for a user's guide to qualitative methods. Thousand Oaks: Sage; 2002.
34.
go back to reference Choukem S-P, Nchifor PK, Halle M-P, Nebongo DN, Mboue-Djieka Y, Kaze FF, et al. Knowledge of physicians on chronic kidney disease and their attitudes towards referral, in two cities of Cameroon: a cross-sectional study. BMC Res Notes. 2016;9:29.PubMedCentralCrossRefPubMed Choukem S-P, Nchifor PK, Halle M-P, Nebongo DN, Mboue-Djieka Y, Kaze FF, et al. Knowledge of physicians on chronic kidney disease and their attitudes towards referral, in two cities of Cameroon: a cross-sectional study. BMC Res Notes. 2016;9:29.PubMedCentralCrossRefPubMed
35.
36.
go back to reference Lunney M, Alrukhaimi M, Ashuntantang GE, Bello AK, Bellorin-Font E, Benghanem Gharbi M, et al. Guidelines, policies, and barriers to kidney care: findings from a global survey. Kidney Int Suppl (2011). 2018;8(2):30–40.CrossRef Lunney M, Alrukhaimi M, Ashuntantang GE, Bello AK, Bellorin-Font E, Benghanem Gharbi M, et al. Guidelines, policies, and barriers to kidney care: findings from a global survey. Kidney Int Suppl (2011). 2018;8(2):30–40.CrossRef
37.
go back to reference Walker RC, Walker S, Morton RL, Tong A, Howard K, Palmer SC. Māori patients' experiences and perspectives of chronic kidney disease: a New Zealand qualitative interview study. BMJ Open. 2017;7(1):e013829.PubMedCentralCrossRefPubMed Walker RC, Walker S, Morton RL, Tong A, Howard K, Palmer SC. Māori patients' experiences and perspectives of chronic kidney disease: a New Zealand qualitative interview study. BMJ Open. 2017;7(1):e013829.PubMedCentralCrossRefPubMed
38.
go back to reference Htay H, Alrukhaimi M, Ashuntantang GE, Bello AK, Bellorin-Font E, Benghanem Gharbi M, et al. Global access of patients with kidney disease to health technologies and medications: findings from the global kidney health atlas project. Kidney Int Suppl. 2018;8(2):64–73.CrossRef Htay H, Alrukhaimi M, Ashuntantang GE, Bello AK, Bellorin-Font E, Benghanem Gharbi M, et al. Global access of patients with kidney disease to health technologies and medications: findings from the global kidney health atlas project. Kidney Int Suppl. 2018;8(2):64–73.CrossRef
39.
40.
go back to reference Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage. 2007;30(1):21–9.CrossRefPubMed Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage. 2007;30(1):21–9.CrossRefPubMed
42.
go back to reference Okel J, Okpechi IG, Qarni B, Olanrewaju T, Courtney MJ, Luyckx V, et al. Nephrology training curriculum and implications for optimal kidney care in the developing world. Clin Nephrol. 2016;86(13):110–3.CrossRefPubMed Okel J, Okpechi IG, Qarni B, Olanrewaju T, Courtney MJ, Luyckx V, et al. Nephrology training curriculum and implications for optimal kidney care in the developing world. Clin Nephrol. 2016;86(13):110–3.CrossRefPubMed
43.
go back to reference Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen S-C, et al. Early detection of kidney disease in community settings: the kidney early evaluation program (KEEP). Am J Kidney Dis. 2003;42(1):22–35.CrossRefPubMed Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen S-C, et al. Early detection of kidney disease in community settings: the kidney early evaluation program (KEEP). Am J Kidney Dis. 2003;42(1):22–35.CrossRefPubMed
45.
go back to reference Jeet G, Thakur JS, Prinja S, Singh M. Community health workers for non-communicable diseases prevention and control in developing countries: evidence and implications. PLoS One. 2017;12(7):e0180640.PubMedCentralCrossRefPubMed Jeet G, Thakur JS, Prinja S, Singh M. Community health workers for non-communicable diseases prevention and control in developing countries: evidence and implications. PLoS One. 2017;12(7):e0180640.PubMedCentralCrossRefPubMed
46.
go back to reference Glaser J, Lemery J, Rajagopalan B, Diaz HF, García-Trabanino R, Taduri G, et al. Climate change and the emergent epidemic of CKD from heat stress in rural communities: the case for heat stress nephropathy. Clin J Am Soc Nephrol. 2016;11(8):1472–83.PubMedCentralCrossRefPubMed Glaser J, Lemery J, Rajagopalan B, Diaz HF, García-Trabanino R, Taduri G, et al. Climate change and the emergent epidemic of CKD from heat stress in rural communities: the case for heat stress nephropathy. Clin J Am Soc Nephrol. 2016;11(8):1472–83.PubMedCentralCrossRefPubMed
47.
go back to reference Joshi R, John O, Jha V. The potential Impact of public health interventions in preventing kidney disease. Semin Nephrol. 2017;37(3):234–44.CrossRefPubMed Joshi R, John O, Jha V. The potential Impact of public health interventions in preventing kidney disease. Semin Nephrol. 2017;37(3):234–44.CrossRefPubMed
48.
go back to reference Legido-Quigley H, Naheed A, de Silva HA, Jehan I, Haldane V, Cobb B, et al. Patients' experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: a qualitative study. PLoS One. 2019;14(1):e0211100.PubMedCentralCrossRefPubMed Legido-Quigley H, Naheed A, de Silva HA, Jehan I, Haldane V, Cobb B, et al. Patients' experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: a qualitative study. PLoS One. 2019;14(1):e0211100.PubMedCentralCrossRefPubMed
Metadata
Title
Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators
Authors
Tazeen Hasan Jafar
Chandrika Ramakrishnan
Oommen John
Abha Tewari
Benjamin Cobb
Helena Legido-Quigley
Yoon Sungwon
Vivekanand Jha
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2020
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-020-1702-6

Other articles of this Issue 1/2020

BMC Nephrology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.